1. Home
  2. IH vs ENTX Comparison

IH vs ENTX Comparison

Compare IH & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.42

Market Cap

70.5M

Sector

Real Estate

ML Signal

HOLD

Logo Entera Bio Ltd.

ENTX

Entera Bio Ltd.

HOLD

Current Price

$1.63

Market Cap

58.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
ENTX
Founded
1996
2010
Country
China
Israel
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
70.5M
58.2M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
IH
ENTX
Price
$1.42
$1.63
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
5.4K
2.9M
Earning Date
03-31-2026
05-14-2026
Dividend Yield
5.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.07
Revenue
N/A
$42,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$7.30
$23.14
Revenue Growth
N/A
N/A
52 Week Low
$1.33
$0.91
52 Week High
$3.60
$3.22

Technical Indicators

Market Signals
Indicator
IH
ENTX
Relative Strength Index (RSI) 46.17 58.70
Support Level N/A $1.45
Resistance Level $1.53 $1.85
Average True Range (ATR) 0.05 0.16
MACD 0.01 -0.01
Stochastic Oscillator 31.27 47.12

Price Performance

Historical Comparison
IH
ENTX

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources. All of the groups revenue is generated from Chinese Mainland.

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to perform. Its product candidates are: EB613, which is being developed as an oral, osteoanabolic (bone-building) tablet treatment for osteoporosis; EB612, being developed as an oral PTH(1-34) tablet peptide replacement therapy for patients with hypoparathyroidism; EB618, an Oral GLP-1 being developed to tackle obesity; and Oral GLP-2, a peptide tablet alternative for patients suffering from short bowel syndrome. The company operates in Israel.

Share on Social Networks: